1. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev. 1995; 8:389–405.
Article
2. Acuña-Villaorduña C, White LF, Fennelly KP, Jones-López EC. Tuberculosis transmission: sputum vs aerosols. Lancet Infect Dis. 2016; 16:770–771.
3. Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology. 2010; 15:413–432.
Article
6. Lee WG, Kwak YS, Lee DH, Hwang YS, Lee KN. Clinical pathology laboratory inspection and accreditation in Korea I: Development of the system and its trial. Korean J Clin Pathol. 2001; 21:86–92.
8. Cousins DV, Bastida R, Cataldi A, Quse V, Redrobe S, Dow S, et al. Tuberculosis in seals caused by a novel member of the
Mycobacterium tuberculosis complex:
Mycobacterium pinnipedii sp. Int J Syst Evol Microbiol. 2003; 53:1305–1314.
Article
10. Center for Disease Control and National Institute of Health. U.S. Biosafety in Microbiological and Biomedical Laboratories. Dept of Health and Human Services. 4th Edition. Washington, DC: Government Printing Office;1999. N° 93-8395. U.S.
11. Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Fieder HL. Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis. 2007; 11:138–142.